Atropine Sulfate Injection, Solution
Product Images NDC 70121-1706

7 FDA label images from Amneal Pharmaceuticals Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Atropine Sulfate (NDC 70121-1706). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Atropine Sulfate Injection 1)

Chemical Structure (Atropine Sulfate Injection 1)
Chemical structure of atropine sulfate, showing its molecular arrangement including the atropine moiety complexed with sulfate and water molecules as part of its sulfate salt form.*
FDA Label Image

Pfs Lbl 5 mg (Atropine Sulfate Injection 2)

Pfs Lbl 5 mg (Atropine Sulfate Injection 2)
Atropine Sulfate Injection USP label for intravenous use by Amneal Pharmaceuticals LLC. The label shows strengths of 0.5 mg and 0.1 mg/mL, with a 5 mL single-dose syringe. Additional details include NDC 70121-1705-1 and manufacturing information indicating the product is made in India and distributed in Bridgewater, NJ.*
FDA Label Image

5.1 (Atropine Sulfate Injection 3)

5.1 (Atropine Sulfate Injection 3)
Packaging label for Atropine Sulfate Injection, USP 0.5 mg/5 mL (0.1 mg/mL) solution for intravenous use. The product is presented in a 5 mL single-dose syringe. Labeler information shows Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals Pvt. Ltd. Instructions for aseptic technique and composition details are partially visible on the label.*
FDA Label Image

5.10 (Atropine Sulfate Injection 4)

5.10 (Atropine Sulfate Injection 4)
Atropine sulfate injection, USP 0.5 mg/5 mL (0.1 mg/mL) in single-dose syringes by Amneal Pharmaceuticals LLC. The label indicates intravenous use and includes details on active ingredients, storage instructions, and manufacturer information. Packaging includes 10 syringes of 5 mL each, NDC 70121-1705-7.*
FDA Label Image

Pfs Lbl 10 mg (Atropine Sulfate Injection 5)

Pfs Lbl 10 mg (Atropine Sulfate Injection 5)
Label for Atropine Sulfate Injection, USP 1 mg/10 mL (0.1 mg/mL) in a 10 mL single-dose syringe. The product is for intravenous use, distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ. The label includes NDC 70121-1706-1, lot and expiration date placeholders, and a barcode. Manufactured in India.*
FDA Label Image

10.1 (Atropine Sulfate Injection 6)

10.1 (Atropine Sulfate Injection 6)
Packaging label for Atropine Sulfate Injection, USP, 1 mg/10 mL (0.1 mg/mL) intravenous solution in a 10 mL single-dose syringe. Label shows Amneal Pharmaceuticals LLC as the distributor and Amneal Pharmaceuticals Pvt. Ltd. as the manufacturer. The label includes usage instructions, storage conditions, and ingredient information.*
FDA Label Image

24 (Atropine Sulfate Injection 7)

24 (Atropine Sulfate Injection 7)
Label for Atropine Sulfate Injection, USP, 1 mg/10 mL (0.1 mg/mL) intravenous injection solution. The label states it is for intravenous use, lists active ingredient content per mL, storage conditions, manufacturer Amneal Pharmaceuticals Pvt. Ltd. India, distributor Amneal Pharmaceuticals LLC, and packaging as 24 single-dose 10 mL syringes. Barcode and revision date are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.